Patents by Inventor Kieran F. Geoghegan

Kieran F. Geoghegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prolonged delivery of peptides
    Patent number: 6828303
    Abstract: There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1 (7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: December 7, 2004
    Assignee: Scios, Inc.
    Inventors: Yesook Kim, William J. Lambert, Hong Qi, Robert A. Gelfand, Kieran F. Geoghegan, Dennis E. Danley
  • Prolonged delivery of peptides
    Publication number: 20030050237
    Abstract: There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1 (7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.
    Type: Application
    Filed: August 31, 2001
    Publication date: March 13, 2003
    Applicant: Scios Inc.
    Inventors: Yesook Kim, William J. Lambert, Hong Qi, Robert A. Gelfand, Kieran F. Geoghegan, Dennis E. Danley
  • Prolonged delivery of peptides
    Patent number: 6284727
    Abstract: There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1 (7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 4, 2001
    Assignee: Scios, Inc.
    Inventors: Yesook Kim, William J. Lambert, Hong Qi, Robert A Gelfand, Kieran F. Geoghegan, Dennis E. Danley
  • Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
    Patent number: 5362852
    Abstract: A process is disclosed for site-directed chemical modification of peptides and proteins that consists of two steps; (a) selective oxidation of a 2-hydroxyethylamine moiety, --CH(NH.sub.2)--CH(OH)--, in the peptide or protein to generate an aidehyde, and (b) reaction of the new aldehyde with a second reagent to form a product in which the native biological properties of the peptide are augmented by new and useful properties conferred by the second reagent. Additionally, the invention pertains to certain specified types of product formed by the above process.
    Type: Grant
    Filed: September 27, 1991
    Date of Patent: November 8, 1994
    Assignee: Pfizer Inc.
    Inventor: Kieran F. Geoghegan